Diagnosis and management of atopic dermatitis, a type of eczema, are complicated by skin temperature fluctuations, unclear ...

An online team-based teledermatology model provides quality-of-life improvements equivalent to in-person care, according to the results of a randomized trial.

There are a number of misconceptions about the use of biologic medications for atopic dermatitis. Find out what experts say ...

Organon Dermatology to present new Phase 3 analysis of VTAMA eczema data at the Society for Pediatric Dermatology annual meeting on July 23, 2026.

Turn Therapeutics, Inc. (NASDAQ: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced the completion of a ...

A study finds that a team-based online care model results in equivalent improvements in atopic dermatitis severity and ...

Turn Therapeutics, Inc. (NASDAQ: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced it will host a live webcast ...

Upadacitinib is associated with sustained or improved responses across various patient-reported outcome measures at 140 weeks among those with AD.

Credit: Getty Images. Clinical phenotypes of atopic dermatitis can vary greatly based on skin color and can make atopic dermatitis difficult to diagnose. Recognizing the clinical diversity of ...

The company plans to begin its global late-stage program in moderate-to-severe atopic dermatitis by the end of July 2026. ・In alopecia areata, a condition that causes hair loss, Nektar reported ...

Dupilumab demonstrated robust efficacy, durable benefits, and a favorable safety profile in children with moderate-to-severe ...

Red, itchy, and scaly skin from atopic dermatitis and eczema can be uncomfortable, confusing, and all too familiar. These chronic (meaning they can last a long time) inflammatory conditions can appear ...